Medicine injector
Latest Novartis AG Patents:
- Regimens and methods of treating multiple sclerosis using ofatumumab
- Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant fc fusion proteins
- Pharmaceutical products and stable liquid compositions of IL-17 antibodies
- Reversal binding agents for anti-factor XI/XIa antibodies and uses thereof
- Injection device and injection solution transferring system
Description
The broken lines shown in
Claims
The ornamental design for a medicine injector, as shown and described.
Patent History
Patent number: D677381
Type: Grant
Filed: Jun 12, 2012
Date of Patent: Mar 5, 2013
Assignee: Novartis AG (Basel)
Inventors: Nicholas Charles Stones (Basel), Martin James Dinnage (Cambridge), Serge Roux (Cambridge, MA), Jeremy Alan Van Hill (Boston, MA), Timothy Duncan Wooller (London), Andy Duncan Pidgeon (Cambridge), Alan Leslie Hawkins (Kent)
Primary Examiner: David Muller
Application Number: 29/424,442
Type: Grant
Filed: Jun 12, 2012
Date of Patent: Mar 5, 2013
Assignee: Novartis AG (Basel)
Inventors: Nicholas Charles Stones (Basel), Martin James Dinnage (Cambridge), Serge Roux (Cambridge, MA), Jeremy Alan Van Hill (Boston, MA), Timothy Duncan Wooller (London), Andy Duncan Pidgeon (Cambridge), Alan Leslie Hawkins (Kent)
Primary Examiner: David Muller
Application Number: 29/424,442
Classifications
Current U.S. Class:
Hand Actuated Flow Control (e.g., Lever, Button, Etc.) (D24/113)